Julie Hambleton - 20 Jun 2023 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Director
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
Issuer symbol
SWTX
Transactions as of
20 Jun 2023
Net transactions value
-$64,603
Form type
4
Filing time
22 Jun 2023, 16:06:40 UTC
Previous filing
25 May 2023
Next filing
26 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Sale $64,603 -2,400 -25% $26.92 7,066 20 Jun 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 17, 2023.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.44 to $27.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.